Benign prostatic hyperplasia. Medical and minimally invasive treatment options.

Benign prostatic hyperplasia is a nonmalignant enlargement of the prostate that is due to excessive cellular growth of both the glandular and the stromal elements of the gland. The condition is ver...

[1]  C. Dotter,et al.  Transluminally-placed coilspring endarterial tube grafts. Long-term patency in canine popliteal artery. , 1969, Investigative radiology.

[2]  M. Barry,et al.  Epidemiology and natural history of benign prostatic hyperplasia. , 1990, The Urologic clinics of North America.

[3]  M. Caron,et al.  Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype. , 1990, The Journal of biological chemistry.

[4]  D McLerran,et al.  Further study of the increased mortality following transurethral prostatectomy: a chart-based analysis. , 1990, The Journal of urology.

[5]  K. Kawabe,et al.  Use of an α1-Blocker, YM617, in the Treatment of Benign Prostatic Hypertrophy , 1990 .

[6]  J. Kabalin.  Laser prostatectomy performed with a right angle firing neodymium:YAG laser fiber at 40 watts power setting. , 1995, The Journal of urology.

[7]  T. Gasser,et al.  Controversies about indications for transurethral resection of the prostate. , 1989, The Journal of urology.

[8]  J H Wasson,et al.  A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. , 1995, The New England journal of medicine.

[9]  H. Lepor,et al.  Randomized double-blind study comparing the effectiveness of balloon dilation of the prostate and cystoscopy for the treatment of symptomatic benign prostatic hyperplasia. , 1992, The Journal of urology.

[10]  T. Gasser,et al.  Transurethral incision versus transurethral resection of the prostate for the treatment of benign prostatic hypertrophy. A preliminary report. , 1987, Scandinavian journal of urology and nephrology. Supplementum.

[11]  H. Guess,et al.  The effect of finasteride on prostate‐specific antigen in men with benign prostatic hyperplasia , 1993, The Prostate.

[12]  S. Meretyk,et al.  A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction. , 1978, British journal of urology.

[13]  J. Oesterling,et al.  The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia. , 1989, The Journal of urology.

[14]  E. Stoner,et al.  Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia. , 1994, Urology.

[15]  M. Barry,et al.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. , 1992, The Journal of urology.

[16]  P. Madsen,et al.  Transurethral resection versus transurethral incision of the prostate. A prospective randomized study. , 1990, The Urologic clinics of North America.

[17]  A. Yerushalmi,et al.  Localized deep microwave hyperthermia in the treatment of poor operative risk patients with benign prostatic hyperplasia. , 1985, The Journal of urology.

[18]  C. Huggins,et al.  The Effect of Castration on Benign Hypertrophy of the Prostate in Man11This investigation was supported by a grant from the Committee on Research in Problems of Sex of the National Research Council. , 1940 .

[19]  J. Oesterling,et al.  A permanent, epithelializing stent for the treatment of benign prostatic hyperplasia. Preliminary results. , 1991, Journal of andrology.

[20]  J. Reese,et al.  Medical therapy alone for the treatment of gas forming intrarenal abscess. , 1994, The Journal of urology.

[21]  Oesterling Je,et al.  Transurethral incision of the prostate: a viable alternative to transurethral resection. , 1992 .

[22]  C. Servadio,et al.  Local hyperthermia for treatment of carcinoma of the prostate: A preliminary report , 1982, The Prostate.

[23]  H. Lepor,et al.  The efficacy of transurethral resection of the prostate in men with moderate symptoms of prostatism. , 1990, The Journal of urology.

[24]  S. Husted,et al.  Doxazosin Treatment in Patients with Prostatic Obstruction , 1993 .

[25]  R. Bruskewitz,et al.  3-year followup of urinary symptoms after transurethral resection of the prostate. , 1986, The Journal of urology.

[26]  C. Ogden,et al.  Sham versus transurethral microwave thermotherapy in patients with symptoms of benign prostatic bladder outflow obstruction , 1993, The Lancet.

[27]  I. Thompson,et al.  Transparenchymal suture fixation and testicular histology in a prepubertal rat model. , 1993, The Journal of urology.

[28]  R J Krane,et al.  The flow rate nomogram: II. Clinical correlation. , 1980, The Journal of urology.

[29]  F Joffre,et al.  Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. , 1987, The New England journal of medicine.

[30]  K McPherson,et al.  Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. , 1989, The New England journal of medicine.

[31]  M. Caine,et al.  The use of alpha-adrenergic blockers in benign prostatic obstruction. , 1976, British journal of urology.

[32]  Z. Petrovich,et al.  Transurethral hyperthermia for benign prostatic hyperplasia: preliminary clinical results. , 1990, The Journal of urology.

[33]  A. Costello,et al.  Laser ablation of the prostate in patients with benign prostatic hypertrophy. , 1992, British journal of urology.

[34]  R. Clarke.  THE PROSTATE AND THE ENDOCRINES: A Control Series* , 1937 .

[35]  J. D. Wilson,et al.  Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. , 1974, The New England journal of medicine.

[36]  J. Blum,et al.  Gonadotropin-releasing hormone stimulation of luteinizing hormone release: A ligand-receptor-effector model. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[37]  G Jones,et al.  A new look at bladder neck obstruction by the food and drug administration regulators: guide lines for investigation of benign prostatic hypertrophy. , 1976, Transactions of the American Association of Genito-Urinary Surgeons.

[38]  Z. Braf,et al.  Complications in hyperthermia treatment of benign prostatic hyperplasia. , 1990, The Journal of urology.

[39]  C. Servadio,et al.  Carcinoma of the prostate in israel: Some epidemiological and therapeutic considerations , 1984, The Prostate.

[40]  R C Bruskewitz,et al.  Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. Measurement Committee of the American Urological Association. , 1992, The Journal of urology.

[41]  R. Gordon,et al.  The treatment of benign prostatic hypertrophy with flutamide (SCH: 13521): a placebo-controlled study. , 1975, The Journal of urology.

[42]  C C Schulman,et al.  Transurethral needle ablation (TUNA): safety, feasibility, and tolerance of a new office procedure for treatment of benign prostatic hyperplasia. , 1993, European urology.

[43]  R. Barnes,et al.  Progression of Obstruction and Symptoms , 1983 .

[44]  H. Bensadoun,et al.  Alfuzosin for treatment of benign prostatic hypertrophy , 1991, The Lancet.

[45]  J. Oesterling,et al.  Effect of finasteride on serum PSA concentration in men with benign prostatic hyperplasia. Results from the North American phase III clinical trial. , 1993, The Urologic clinics of North America.

[46]  P. Abrams,et al.  The natural history of untreated "prostatism". , 1981, British journal of urology.

[47]  J. E. Oesterling.  Benign prostatic hyperplasia. Its natural history, epidemiologic characteristics, and surgical treatment. , 1992, Archives of family medicine.

[48]  J. Oesterling.  LHRH agonists. A nonsurgical treatment for benign prostatic hyperplasia. , 1991, Journal of andrology.

[49]  J. Vukusic,et al.  Transurethral microwave treatment for benign prostatic hypertrophy: a randomised controlled clinical trial. , 1993, BMJ.

[50]  T. Hald.  Urodynamics in benign prostatic hyperplasia: A survey , 1989, The Prostate. Supplement.

[51]  Treatment response with transurethral microwave hyperthermia in different forms of benign prostatic hyperplasia: A preliminary report , 1991, The Prostate.

[52]  R. Kirby,et al.  Prazosin in the treatment of prostatic obstruction. A placebo-controlled study. , 1987, British journal of urology.

[53]  H. Lepor,et al.  The alpha‐adrenoceptor subtype mediating the tension of human prostatic smooth muscle , 1993, The Prostate.

[54]  T. Krarup,et al.  Transurethral prostatectomy or incision of the prostate in the treatment of prostatism caused by small benign prostates. , 1987, Scandinavian Journal of Urology and Nephrology, Supplementum.

[55]  C. Chapple,et al.  The UroLume stent in the management of benign prostatic hyperplasia. , 1993, The Journal of urology.

[56]  G. Andriole,et al.  The effect of finasteride in men with benign prostatic hyperplasia. , 1992, The Journal of urology.

[57]  P. Abel,et al.  Comparison of alpha 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 4101. , 1988, Molecular pharmacology.

[58]  H. Lepor,et al.  A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. , 1992, The Journal of urology.

[59]  R. Huben,et al.  Locally recurrent endometrioid adenocarcinoma of the prostate after radical prostatectomy. , 1991, The Journal of urology.

[60]  E. Stoner.  The clinical development of a 5α-reductase inhibitor, finasteride , 1990, The Journal of Steroid Biochemistry and Molecular Biology.

[61]  H. Lepor.  Medical therapy for benign prostatic hyperplasia. , 1993, Urology.

[62]  N. Stone,et al.  Response of prostate volume, prostate-specific antigen, and testosterone to flutamide in men with benign prostatic hyperplasia. , 1991, Journal of andrology.

[63]  P. Iversen,et al.  A Point System for Selecting Operative Candidates , 1983 .

[64]  O. Lukkarinen,et al.  Bladder neck incision or transurethral electroresection for the treatment of urinary obstruction caused by a small benign prostate? A randomized urodynamic study. , 1986, Scandinavian journal of urology and nephrology.

[65]  S. Raz,et al.  Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. , 1975, British journal of urology.

[66]  R K Babayan,et al.  Transurethral ultrasound-guided laser-induced prostatectomy: National Human Cooperative Study results. , 1993, The Journal of urology.

[67]  P. Miller,et al.  Use of the ASI titanium stent in the management of bladder outflow obstruction due to benign prostatic hyperplasia. , 1992, The Journal of urology.

[68]  R. E. Peterson,et al.  Steroid 5α-Reductase Deficiency in Man: An Inherited Form of Male Pseudohermaphroditism , 1974, Science.

[69]  J. Lingeman,et al.  Creatinine kinase concentrations and electrocardiographic changes in extracorporeal shock-wave lithotripsy. , 1988, Urology.

[70]  A T Cockett,et al.  Transurethral prostatectomy: practice aspects of the dominant operation in American urology. , 1989, The Journal of urology.

[71]  M. Marberger,et al.  Tissue ablation in benign prostatic hyperplasia with high intensity focused ultrasound. , 1994, The Journal of urology.

[72]  C. Chapple,et al.  Efficacy and safety of the alpha-1 blocker doxazosin in the treatment of benign prostatic hyperplasia. Analysis of 5 studies. Doxazosin Study Groups. , 1993, European urology.

[73]  H. Lepor,et al.  Alpha 1 adrenoceptor subtypes in the human prostate. , 1993, The Journal of urology.

[74]  M. Bornman,et al.  Sclerotherapy for hydroceles. , 1990, The Journal of urology.

[75]  H. Noto,et al.  Microwave surgical treatment of diseases of prostate. , 1985, Urology.

[76]  G. Drach,et al.  A method of adjustment of male peak urinary flow rate for varying age and volume voided. , 1982, The Journal of urology.

[77]  C. Dixon,et al.  Laser ablation of the prostate. , 1992, Seminars in urology.

[78]  P. J. Clark,et al.  QUANTITATIVE STUDIES OF PROSTATIC SECRETION : II. THE EFFECT OF CASTRATION AND OF ESTROGEN INJECTION ON THE NORMAL AND ON THE HYPERPLASTIC PROSTATE GLANDS OF DOGS. , 1940 .

[79]  J. Isaacs.  Importance of the natural history of benign prostatic hyperplasia in the evaluation of pharmacologic intervention , 1990, The Prostate. Supplement.

[80]  C. Servadio,et al.  Local thermotherapy of the benign prostate: a 1-year follow-up. , 1990, European urology.

[81]  Edward J. McGuire.  The role of urodynamic investigation in the assessment of benign prostatic hypertrophy. , 1992, The Journal of urology.

[82]  M. Devonec,et al.  Transurethral microwave heating of the prostate ― or from hyperthermia to thermotherapy , 1991 .

[83]  J. Lynch,et al.  Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: results of the United States Prostatron Cooperative Study. , 1993, The Journal of urology.

[84]  C. Chapple,et al.  A NEW TREATMENT FOR URETHRAL STRICTURES , 1988, The Lancet.

[85]  H H Zinsser,et al.  Natural history of benign prostatic hypertrophy and acute urinary retention. , 1976, Urology.